Skip to content
Last week, the U.S. Food and Drug Administration (FDA) approved Pfizer and BioNTech’s supplemental Biologics License Application (sBLA) for their COVID-19 vaccine, Comirnaty, for […]
FDA gives full approval to Pfizer-BioNTech COVID vaccine for teenagers Read More »
State-licensed pharmacists in the United States are now authorized to prescribe Pfizer’s COVID-19 pill Paxlovid to eligible patients, with certain limitations to ensure appropriate
Pharmacists authorized to prescribe Paxlovid, FDA says Read More »
Democrats filed a proposal for drug price controls with the Senate Parliamentarian on Wednesday, seeking to classify the bill as “budget reconciliation,” so it
Senate Democrats move forward on drug price controls Read More »
In comments to the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), the biotech sector suggests the agency needs to
BIO: APHIS strategy needs regulatory clarity to boost innovation Read More »
A recently published report from the University of Chicago shows drug price controls would decrease spending on cancer drug R&D by almost 10 times
Study: Price controls would reduce cancer R&D spending by 31% Read More »
The Food and Drug Administration (FDA) recommended COVID vaccine manufacturers modify the next round of COVID-19 booster shots to target the extremely contagious Omicron
FDA: Omicron variants should be included in fall boosters Read More »
The Supreme Court limited the Environmental Protection Agency’s (EPA) ability to regulate carbon emissions from power plants on Thursday, ruling 6-3 that “Congress had
Supreme Court limits EPA’s ability to reduce power plant emissions Read More »
The House Appropriations Committee is set to mark up today the fiscal year 2023 spending bill for Health and Human Services (HHS), which would
Healthcare spending bill draft includes many BIO requests Read More »
As monkeypox virus cases increase in the United States, the Biden administration will begin distributing the monkeypox vaccine around the country, focusing on persons
U.S. to distribute 1.6 million doses of monkeypox vaccine by year’s end Read More »
The Vaccine and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) voted 19-2 in favor of including Omicron variants
FDA advisers call for Omicron-specific boosters Read More »
